![Pharmaceuticals | Free Full-Text | CRISPR-Cas Technology: Emerging Applications in Clinical Microbiology and Infectious Diseases Pharmaceuticals | Free Full-Text | CRISPR-Cas Technology: Emerging Applications in Clinical Microbiology and Infectious Diseases](https://pub.mdpi-res.com/pharmaceuticals/pharmaceuticals-14-01171/article_deploy/html/images/pharmaceuticals-14-01171-g001.png?1637219358)
Pharmaceuticals | Free Full-Text | CRISPR-Cas Technology: Emerging Applications in Clinical Microbiology and Infectious Diseases
![Extrachromosomal Circular DNAs, Amplified Oncogenes, and CRISPR-Cas9 System | Molecular Pharmacology Extrachromosomal Circular DNAs, Amplified Oncogenes, and CRISPR-Cas9 System | Molecular Pharmacology](https://molpharm.aspetjournals.org/sites/default/files/highwire/molpharm/102/4.cover-source.jpg)
Extrachromosomal Circular DNAs, Amplified Oncogenes, and CRISPR-Cas9 System | Molecular Pharmacology
BIBLIOGRAPHY Auer, Albert. Der Mensch hat Recht. Naturrecht auf dem Hin grund des Heute. Verlag Styria, Graz, Wien, Köln 1956.
![CvkR is a MerR-type transcriptional repressor of class 2 type V-K CRISPR-associated transposase systems | Nature Communications CvkR is a MerR-type transcriptional repressor of class 2 type V-K CRISPR-associated transposase systems | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-023-36542-9/MediaObjects/41467_2023_36542_Fig1_HTML.png)